Prediction of rebleeding after capsule endoscopy (CE) in obscure gastrointestinal bleeding (OGIB) is challenging. The RHEMITT score recently described includes 7 variables: chronic kidney disease (CKD); heart failure (HF), P1 / P2 injuries (Saurin's classification); major hemorrhage (drop in hemoglobin> 2d / dLor need for transfusion> 2U GR); incomplete examination; smoking and endoscopic treatment. This tool has been shown to accurately predict the risk of recurrence after an EC study.The primaryaim of this study was to performexternal validation of the RHEMITTscore.Prediction of rebleeding after capsule endoscopy (CE) in obscure gastrointestinal bleeding (OGIB) is challenging. The RHEMITT score recently described includes 7 variables: chronic kidney disease (CKD); heart failure (HF), P1 / P2 injuries (Saurin's classification); major hemorrhage (drop in hemoglobin> 2d / dLor need for transfusion> 2U GR); incomplete examination; smoking and endoscopic treatment. This tool has been shown to accurately predict the risk of recurrence after an EC study.The primaryaim of this study was to performexternal validation of the RHEMITTscore.